| A Prospective Study of Variation in Breath Holding Times at Various Phases of Respiration During the Course of Radiotherapy Including the Effect of Respiratory Training in Lung Cancer Patients (NCT01429766) | Tata Memorial Hospital | 2010-06-01 |
| Endobronchial Ultrasound Guided Transbronchial Aspiration (EBUS-TBNA) in Non Small Cell Lung Cancer (NSCLC) in a Tuberculosis-endemic Country (NCT01156623) | Chang Gung Memorial Hospital | 2010-06-01 |
| Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001) (NCT01158170) | Zhejiang Cancer Hospital | 2010-06-01 |
| Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes (NCT01159288) | Gustave Roussy, Cancer Campus, Grand Paris | 2010-05-19 |
| Customizing First Line Chemotherapy in Advanced Non-Small Cell Lung Cancer (NCT01356368) | National Guard Health Affairs | 2010-05-01 |
| Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC) (NCT01137968) | Geron Corporation | 2010-05-01 |
| Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung Cancer (NCT01107444) | Eli Lilly and Company | 2010-05-01 |
| 131I-L19SIP Radioimmunotherapy Combined With Radiochemotherapy in Patients With Locally-advanced Non Small Cell Lung Cancer (NSCLC) (NCT01124812) | Philogen S.p.A. | 2010-05-01 |
| Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC) (NCT00864110) | Cell>Point LLC | 2010-04-01 |
| Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin (NCT00966914) | BioNumerik Pharmaceuticals, Inc. | 2010-04-01 |
| Pazopanib and Paclitaxel for Non-Small Cell Lung Cancer (NCT01179269) | Loyola University | 2010-03-01 |
| Proton Beam Radiation With Concurrent Chemotherapy and Nelfinavir for Inoperable Stage III Non Small Cell Lung Cancer (NSCLC) (NCT01108666) | Abramson Cancer Center at Penn Medicine | 2010-03-01 |
| A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer (NCT01270386) | Jiangsu HengRui Medicine Co., Ltd. | 2010-03-01 |
| Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) (NCT01081496) | AstraZeneca | 2010-03-01 |
| Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy (NCT02486354) | Betta Pharmaceuticals Co., Ltd. | 2010-03-01 |
| Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP) (NCT01103089) | AstraZeneca | 2010-03-01 |
| Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer (NCT00888823) | AHS Cancer Control Alberta | 2010-03-01 |
| Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer (NCT01104155) | Eisai Inc. | 2010-02-22 |
| Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC (NCT00997334) | David M. Jackman, MD | 2010-02-01 |
| Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies (NCT01045421) | Millennium Pharmaceuticals, Inc. | 2010-02-01 |
| Safety Study of Peptide Cancer Vaccine To Treat HLA-A*02-positive Advanced Non-small Cell Lung Cancer (NCT01069640) | Shiga University | 2010-02-01 |
| Thermal Ablation Combined With External Beam Radiation Therapy for Patients With Inoperable Non-Small Cell Lung Cancer > 3.5 cm in Size (NCT01028612) | Wake Forest University Health Sciences | 2010-02-01 |
| A Study of ARQ 197 in Combination With Erlotinib (NCT01069757) | Kyowa Kirin Co., Ltd. | 2010-02-01 |
| Study Comparing EBUS & EUS to Mediastinoscopy in Staging and Detection of Lung Cancer (NCT00970645) | Mayo Clinic | 2010-02-01 |
| Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Non-small Cell Lung Cancer (NCT01069575) | Shiga University | 2010-02-01 |
| Whole-Body Magnetic Resonance Imaging/Positron Emission Tomography (MRI/PET) in the Staging of Non-Small-Cell Lung Cancer (NSCLC) (NCT01065415) | Samsung Medical Center | 2010-02-01 |
| Epidemiological Study to Describe Non Small Cell Lung Cancer (NSCLC) Clinical Management Patterns in Central Eastern Europe and Russia (Lung-EPICLIN) (NCT01069835) | AstraZeneca | 2010-02-01 |
| Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC (NCT01063478) | University of Chicago | 2010-02-01 |
| Bevacizumab Plus Chemotherapy for Advanced Non Small Cell Lung Cancer Patients as 1st Line Treatment (NCT01934465) | Hellenic Oncology Research Group | 2010-02-01 |
| First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin (NCT00981058) | Eli Lilly and Company | 2010-01-07 |
| Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel (NCT01000896) | AstraZeneca | 2010-01-01 |
| A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT00918203) | Eli Lilly and Company | 2010-01-01 |
| Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer (NCT01481259) | People's Hospital of Guangxi Zhuang Autonomous Region | 2010-01-01 |
| AI-Based Prediction of Stage and Survival in Non-Small Cell Lung Cancer: A Retrospective Study (NCT07068139) | Hilkat Fatih Elverdi | 2010-01-01 |
| Concomitant Radio-chemotherapy in the Elderly (NCT01029678) | University Hospital, Limoges | 2010-01-01 |
| Breathing Synchronized PET/CT Scans for the Detection of Malignant Lung & Liver Lesions and Assessment of Tumor Glycolysis (NCT01052766) | Memorial Sloan Kettering Cancer Center | 2010-01-01 |
| GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line (NCT01049776) | Illinois CancerCare, P.C. | 2010-01-01 |
| Feasibility Study: Comparison of Performance Status With Objective Physical Activity Monitors (NCT01063400) | University of Wisconsin, Madison | 2010-01-01 |
| First-Line Chemotherapy and Panitumumab in Advanced Non-Small Cell Lung Cancer (NCT01038037) | Vejle Hospital | 2010-01-01 |
| Trial Involving Subjects Over 70 Years of Age With Non Small-cell Lung Cancer of Stage IV and Comparing a "Classical" Strategy of Treatment Allocation, With an"Optimized" Strategy Allocating the Same Treatments (NCT01257139) | Rennes University Hospital | 2010-01-01 |
| Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (NCT01091376) | Zhejiang Cancer Hospital | 2010-01-01 |
| Erlotinib Is Being Studied With Or Without An Investigational Drug, PF-02341066, In Patients With Lung Cancer (NCT00965731) | Pfizer | 2010-01-01 |
| A Trial on Video-assisted Thoracoscopic Surgery and Axillary Thoracotomy for Resection of Early-stage Non-small Cell Lung Cancer (NCT01102517) | Sun Yat-sen University | 2010-01-01 |
| Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response Biomarker (NCT01041833) | National Institute of Cancerología | 2010-01-01 |
| Study to Investigate Bronchial Arterrial Infusing (BAI) Plus Three-dimensional Conformal Radiotherapy (3DCRT) in Local Advanced Non-small Cell Lung Cancer (NSCLC) (NCT01201044) | Third Military Medical University | 2010-01-01 |
| Assessment of Invasive Mediastinal Staging in cN1 Lung Cancer. (NCT01456429) | Universitaire Ziekenhuizen KU Leuven | 2010-01-01 |
| Randomized, Double-Blind Trial of Erlotinib/Pazopanib or Erlotinib/Placebo in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer (NCT01027598) | SCRI Development Innovations, LLC | 2010-01-01 |
| A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma (NCT01051934) | National Cancer Institute (NCI) | 2009-12-29 |
| Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced Cancer (NCT01061840) | Gradalis, Inc. | 2009-12-01 |
| Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer (NCT01196234) | Asan Medical Center | 2009-12-01 |
| Cancer Vaccine Study for Stage III, Unresectable, Non-small Cell Lung Cancer (NSCLC) in the Asian Population (NCT01015443) | Merck KGaA, Darmstadt, Germany | 2009-12-01 |
| Hypofractionated Radiotherapy (Stereotactic) Versus Conventional Radiotherapy for Inoperable Early Stage I Non-small Cell Lung Cancer (NSCLC) (NCT01014130) | Trans Tasman Radiation Oncology Group | 2009-12-01 |
| Study of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC) (NCT01099124) | Tianjin Medical University Cancer Institute and Hospital | 2009-12-01 |
| Tarceva. ICORG 08-41 (NCT01721252) | Cancer Trials Ireland | 2009-12-01 |
| Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer Patients (NCT01192243) | Fudan University | 2009-12-01 |
| Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium (NCT00896454) | Amgen | 2009-11-16 |
| First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin (NCT00982111) | Eli Lilly and Company | 2009-11-02 |
| A Study Comparing Two Different Chemotherapy Types in Chinese Patients With Advanced Non Small Cell Lung Cancer (NCT01005680) | Eli Lilly and Company | 2009-11-01 |
| A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients (NCT01020786) | Eli Lilly and Company | 2009-11-01 |
| A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC) (NCT01031225) | Synta Pharmaceuticals Corp. | 2009-11-01 |
| A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung Cancer (NCT01017874) | Eli Lilly and Company | 2009-11-01 |
| Taxotere-Enoxaparin-(ENOXA)-Study (NCT01058759) | Hannover Medical School | 2009-11-01 |
| Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer (NCT01004510) | Peter Bushunow MD | 2009-11-01 |
| Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin for Advanced NSCLC Metastatic Non-small Cell Lung Cancer (NCT01194453) | Sun Yat-sen University | 2009-11-01 |
| A Study of Advanced or Metastatic Non-small Cell Lung Cancer (NCT00988858) | Eli Lilly and Company | 2009-11-01 |
| An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors (NCT01040312) | Daiichi Sankyo Co., Ltd. | 2009-10-15 |
| Phase I Study of Accelerated Hypofractionated Image-Guided Radiation Therapy (NCT03623334) | University of Texas Southwestern Medical Center | 2009-10-05 |
| Study to Evaluate SID 530 Compared to Taxotere (NCT00931008) | SK Chemicals Co., Ltd. | 2009-10-01 |
| Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations (NCT00977470) | Massachusetts General Hospital | 2009-10-01 |
| Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC) (NCT00995761) | Gyeongsang National University Hospital | 2009-10-01 |
| A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer (NCT01000480) | Eli Lilly and Company | 2009-10-01 |
| A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer (NCT00970580) | Biogen | 2009-10-01 |
| Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902) (NCT01158144) | Zhejiang Cancer Hospital | 2009-10-01 |
| A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell Cancer (NCT01004250) | Eli Lilly and Company | 2009-10-01 |
| EBUS-guided TBNA for Molecular Diagnostic of Mediastinal Lymph Nodes (LN) (NCT00982605) | Heidelberg University | 2009-10-01 |
| Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies (NCT00921739) | Duke University | 2009-09-11 |
| Epidermal Growth Factor Receptor (EGFR) Status Based Gefitinib Neoadjuvant Therapy in Non Small Cell Lung Cancer (NSCLC) (NCT00986284) | Tianjin Medical University Cancer Institute and Hospital | 2009-09-01 |
| Proton Therapy for Stage I Non-Small Cell Lung Cancer (LU03) (NCT00875901) | University of Florida | 2009-09-01 |
| Study Using WST11 in Patients With Obstructing Endobronchial Non-Small Cell Lung Cancer (NCT00974662) | Steba Biotech S.A. | 2009-09-01 |
| Epidemiologic Study of KRAS Mutation in Brazilian Patients With Advanced or Metastatic Non Small Cell Lung Cancer (NCT00956280) | AstraZeneca | 2009-09-01 |
| Nimotuzumab in Combination With Cisplatin and Docetaxel for Patients With Advanced Non-small Cell Lung Cancer (NCT00985998) | Biotech Pharmaceutical Co., Ltd. | 2009-09-01 |
| Study of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung Cancer (NCT01011075) | New Mexico Cancer Research Alliance | 2009-08-01 |
| Benefits Study of Respiratory-gated PET Acquisition in Lung Disease (NCT01812031) | Centre Hospitalier Universitaire, Amiens | 2009-08-01 |
| The Continuation of Erlotinib (NCT01130779) | Samsung Medical Center | 2009-08-01 |
| Early Prediction of Pathology Response of Chemoradiotherapy With FLT PET (NCT01065818) | Columbia University | 2009-08-01 |
| Preoperative Chemotherapy and Bevacizumab in Patients With Stage IB (>4 cm), II, or Select Stage III NSCLC (NCT00960297) | SCRI Development Innovations, LLC | 2009-08-01 |
| Multicentre Study to Explore the Correlation Between Smoking Pattern and Clinical Efficacy of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Male Patients (NCT00922025) | AstraZeneca | 2009-08-01 |
| A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa (NCT01000740) | AstraZeneca | 2009-08-01 |
| Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy (NCT00858364) | Amgen | 2009-07-17 |
| SORAVE - Sorafenib and Everolimus in Solid Tumors (NCT00933777) | University of Cologne | 2009-07-01 |
| 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors (NCT00967577) | Weill Medical College of Cornell University | 2009-07-01 |
| Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment (NCT02105168) | Gustave Roussy, Cancer Campus, Grand Paris | 2009-07-01 |
| NGR-hTNF in Combination With Standard Chemotherapy to Treat Patients With Advanced Non-small Cell Lung Cancer (NCT00994097) | AGC Biologics S.p.A. | 2009-07-01 |
| Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients (NCT01507740) | Medical University Innsbruck | 2009-07-01 |
| Pemetrexed and LBH589 in Patients With Advanced Non-Small Cell Lung Cancer (NCT00907179) | University of Pittsburgh | 2009-07-01 |
| Efficacy/Safety of Imprime PGG® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreated Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT00874107) | HiberCell, Inc. | 2009-06-01 |
| A Study of Tarceva (Erlotinib) in Sequential Combination With Gemcitabine as First Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer (NCT00940875) | Hoffmann-La Roche | 2009-06-01 |
| Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC) (NCT00865319) | Cell>Point LLC | 2009-06-01 |
| Bortezomib in Combination With Gemcitabine and Cisplatin in Advanced or Metastatic Non-Small Cell Lung Cancer (NCT01633645) | University Hospital of Crete | 2009-06-01 |
| Pemetrexed Plus Oxaliplatin as Adjuvant Chemotherapy for Radically Resected Non-Small Cell Lung Cancer (NCT00923637) | The First Affiliated Hospital of Guangzhou Medical University | 2009-06-01 |